Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Covington
AstraZeneca
Citi
Farmers Insurance
Harvard Business School

Generated: May 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,745,071

« Back to Dashboard

Which drugs does patent 6,745,071 protect, and when does it expire?

Patent 6,745,071 protects ZECUITY and is included in one NDA.

This patent has twelve patent family members in nine countries.

Summary for Patent: 6,745,071
Title: Iontophoretic drug delivery system
Abstract:A reliable, self-contained iontophoretic drug delivery system is disclosed which enjoys a long stable shelf life and which is easy for the user to activate and employ. This system includes a wearable iontophoretic device that is prepackaged as a complete self-contained unit which includes the active species or drug to be administered and counter ions. The system includes a provision for isolating moisture sources from the electrodes and from the power source during storage and provides a simple, user-friendly mechanism to connect the drug to be administered and counter ion reservoirs to the electrodes and the device to the skin of a user in order to activate the device circuit. All elements of the device are contained in a single outer package.
Inventor(s): Anderson; Carter R. (Inver Grove Heights, MN), Morris; Russell L. (Lindstrom, MN), Anderson; Clayton J. (Burnsville, MN), Grace; Lori A. (Lino Lakes, MN)
Assignee: Birch Point Medical, Inc. (Oakdale, MN)
Application Number:10/371,851
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 6,745,071
Patent Claim Types:
see list of patent claims
Delivery; Device;

Drugs Protected by US Patent 6,745,071

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Teva Branded Pharm ZECUITY sumatriptan succinate SYSTEM;IONTOPHORESIS 202278-001 Jan 17, 2013 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 6,745,071

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 518561 ➤ Sign Up
Australia 2003267229 ➤ Sign Up
Canada 2512368 ➤ Sign Up
China 100486656 ➤ Sign Up
China 1780661 ➤ Sign Up
European Patent Office 1599255 ➤ Sign Up
Spain 2395251 ➤ Sign Up
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Daiichi Sankyo
Chubb
McKesson
Farmers Insurance
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.